Prognostic factors for worsening and improvement in multiple sclerosis using a multistate model
Alex Ocampo(Novartis (Switzerland)), Heinz Wiendl(University Medical Center Freiburg), Marie‐Catherine Mousseau(Novartis (Ireland)), Jelena Čuklina(Novartis (Switzerland)), Samantha C. Pendleton(University of Birmingham), Wendy Su(Novartis (Switzerland)), Habib Ganjgahi(University of Warwick), Piet Aarden(Novartis (Switzerland)), Thomas E. Nichols(University of Oxford), Douglas L. Arnold(McGill University), Dieter A. Häring(Novartis (Switzerland)), Farhad Hatami(The George Institute for Global Health), Yang Sun(Shenyang Medical College), Bernd C. Kieseier(Novartis (Switzerland)), Robert A Bermel(Cleveland Clinic), Gordon Graham(Novartis (Switzerland)), Stephen Gardiner(University of Oxford)
Cited by 4
Related Papers
Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data
|NeuroImage|2006|6.6k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
|New England Journal of Medicine|2016|1.9k